Keudell/Morrison Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Buy |
+11,813
| New | +$454K | 0.1% | 129 |
|
|
2022
Q3 | – | Sell |
-3,738
| Closed | -$203K | – | 178 |
|
|
2022
Q2 | $203K | Sell |
3,738
-82
| -2% | -$4.45K | 0.07% | 166 |
|
|
2022
Q1 | $208K | Sell |
3,820
-452
| -11% | -$24.6K | 0.09% | 167 |
|
|
2021
Q4 | $235K | Sell |
4,272
-346
| -7% | -$19K | 0.09% | 166 |
|
|
2021
Q3 | $221K | Buy |
4,618
+5
| +0.1% | +$239 | 0.09% | 162 |
|
|
2021
Q2 | $230K | Buy |
4,613
+26
| +0.6% | +$1.3K | 0.13% | 154 |
|
|
2021
Q1 | $205K | Sell |
4,587
-1,101
| -19% | -$49.2K | 0.12% | 159 |
|
|
2020
Q4 | $262K | Sell |
5,688
-4,942
| -46% | -$228K | 0.17% | 134 |
|
|
2020
Q3 | $500K | Sell |
10,630
-696
| -6% | -$32.7K | 0.32% | 82 |
|
|
2020
Q2 | $577K | Sell |
11,326
-1,796
| -14% | -$91.5K | 0.48% | 72 |
|
|
2020
Q1 | $622K | Sell |
13,122
-1,356
| -9% | -$64.3K | 0.61% | 60 |
|
|
2019
Q4 | $850K | Sell |
14,478
-1,409
| -9% | -$82.7K | 0.59% | 57 |
|
|
2019
Q3 | $848K | Sell |
15,887
-242
| -2% | -$12.9K | 0.7% | 50 |
|
|
2019
Q2 | $817K | Sell |
16,129
-170
| -1% | -$8.61K | 0.72% | 47 |
|
|
2019
Q1 | $851K | Buy |
+16,299
| New | +$851K | 0.75% | 45 |
|